Richard Bergström
Directeur/Membre du Conseil chez ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
Profil
Richard Bergström is the founder of PharmaCCX, Inc. He is currently a Director at ISR Immune System Regulation Holding AB and NorthX Biologics Matfors AB.
Previously, he served as the Director General of the European Federation of Pharmaceutical Industries & Assns from 2011 to 2017.
Postes actifs de Richard Bergström
| Sociétés | Poste | Début |
|---|---|---|
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Directeur/Membre du Conseil | 01/01/2022 |
PharmaCCX, Inc.
 PharmaCCX, Inc. Internet Software/ServicesTechnology Services Pharmaccx, Inc. provides technology exchange platform. Its product enable pharmaceutical firm and payers to speed up their pricing negotiations, getting drugs to patients in need more quickly. The company was founded by Nathan Sigworth and Richard Bergstrom and is headquartered in Boston, MA. | Fondateur | - |
NorthX Biologics Matfors AB
 NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Directeur/Membre du Conseil | 14/06/2022 |
Anciens postes connus de Richard Bergström
| Sociétés | Poste | Fin |
|---|---|---|
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Directeur Général | 30/04/2017 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
ISR Immune System Regulation Holding AB
 ISR Immune System Regulation Holding AB Pharmaceuticals: MajorHealth Technology ISR Immune System Regulation Holding AB engages in pharmaceutical research for the treatment of viral diseases focusing on Human Immunodeficiency Virus (HIV). It is developing ISR048 for the novel treatment of HIV. The company was founded by Yen Lundgren and Ulf Ljungblad in September 17, 2015 and is headquartered in Solna, Sweden. | Health Technology |
PharmaCCX, Inc.
PharmaCCX, Inc. Internet Software/ServicesTechnology Services Pharmaccx, Inc. provides technology exchange platform. Its product enable pharmaceutical firm and payers to speed up their pricing negotiations, getting drugs to patients in need more quickly. The company was founded by Nathan Sigworth and Richard Bergstrom and is headquartered in Boston, MA. | Technology Services |
NorthX Biologics Matfors AB
NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Health Technology |
